company background image
2348 logo

Dawnrays Pharmaceutical (Holdings) SEHK:2348 Voorraadrapport

Laatste prijs

HK$1.23

Marktkapitalisatie

HK$1.8b

7D

-0.8%

1Y

10.8%

Bijgewerkt

16 Oct, 2024

Gegevens

Financiële gegevens bedrijf

Dawnrays Pharmaceutical (Holdings) Limited

SEHK:2348 Voorraadrapport

Marktkapitalisatie: HK$1.8b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

2348 Overzicht aandelen

Dawnrays Pharmaceutical (Holdings) Limited, een investeringsholding, ontwikkelt, produceert en verkoopt niet-gepatenteerde farmaceutische geneesmiddelen op het Chinese vasteland en internationaal.

Dawnrays Pharmaceutical (Holdings) Limited Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Dawnrays Pharmaceutical (Holdings)
Historische aandelenkoersen
Huidige aandelenkoersHK$1.23
52 Week HoogtepuntHK$1.40
52 Week LaagHK$0.98
Bèta0.69
11 maand verandering11.82%
3 maanden verandering3.36%
1 Jaar Verandering10.81%
33 jaar verandering-25.45%
5 jaar verandering-16.33%
Verandering sinds IPO196.39%

Recent nieuws en updates

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Might Not Be As Promising As They Seem

Sep 21
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Might Not Be As Promising As They Seem

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015

Sep 11
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015

Recent updates

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Might Not Be As Promising As They Seem

Sep 21
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Might Not Be As Promising As They Seem

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015

Sep 11
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.065

May 25
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.065

Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.065

Apr 22
Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.065

Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.065

Apr 08
Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.065

Dawnrays Pharmaceutical (Holdings) (HKG:2348) Is Due To Pay A Dividend Of CN¥0.065

Mar 25
Dawnrays Pharmaceutical (Holdings) (HKG:2348) Is Due To Pay A Dividend Of CN¥0.065

Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.015

Aug 30
Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.015

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Shareholders Will Receive A Bigger Dividend Than Last Year

May 26
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Shareholders Will Receive A Bigger Dividend Than Last Year

Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.073

Apr 04
Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.073

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015

Sep 19
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals

Sep 22
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals

Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015

Sep 12
Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015

Aug 29
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015

Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend

Feb 28
Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend

Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?

Feb 07
Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?

Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares

Jan 14
Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares

Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Dec 22
Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?

Dec 09
What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?

Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend

Nov 23
Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend

Rendement voor aandeelhouders

2348HK PharmaceuticalsHK Markt
7D-0.8%-5.9%-3.0%
1Y10.8%18.4%13.8%

Rendement versus industrie: 2348 presteerde slechter dan de Hong Kong Pharmaceuticals -sector, die het afgelopen jaar een rendement van 26.7 % opleverde.

Rendement versus markt: 2348 presteerde slechter dan Hong Kong Market, dat het afgelopen jaar een rendement van 19.7 % opleverde.

Prijsvolatiliteit

Is 2348's price volatile compared to industry and market?
2348 volatility
2348 Average Weekly Movement5.3%
Pharmaceuticals Industry Average Movement6.5%
Market Average Movement8.8%
10% most volatile stocks in HK Market18.4%
10% least volatile stocks in HK Market4.3%

Stabiele aandelenkoers: 2348 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van 2348 is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19951,175Liwei Yuwww.dawnrays.com

Dawnrays Pharmaceutical (Holdings) Limited, een investeringsholding, ontwikkelt, produceert en verkoopt niet-gepatenteerde farmaceutische geneesmiddelen op het Chinese vasteland en internationaal. Het bedrijf is actief in twee segmenten: tussenproducten en bulkgeneesmiddelen, en afgewerkte geneesmiddelen. Het bedrijf biedt antibiotica aan, waaronder farmaceutische tussenproducten, medicijnen in bulk, poeder voor injecties en orale antibiotica.

Dawnrays Pharmaceutical (Holdings) Limited Samenvatting

Hoe verhouden de winst en inkomsten van Dawnrays Pharmaceutical (Holdings) zich tot de beurswaarde?
2348 fundamentele statistieken
MarktkapitalisatieHK$1.82b
Inkomsten(TTM)HK$614.79m
Inkomsten(TTM)HK$1.18b

3.0x

Koers/Winstverhouding

1.6x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
2348 resultatenrekening (TTM)
InkomstenCN¥1.08b
Kosten van inkomstenCN¥493.89m
BrutowinstCN¥584.78m
Overige uitgavenCN¥21.68m
InkomstenCN¥563.11m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)0.38
Brutomarge54.21%
Nettowinstmarge52.20%
Schuld/Eigen Vermogen Verhouding5.6%

Hoe presteerde 2348 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

6.4%

Huidig dividendrendement

19%

Uitbetalingsratio